Comparing cutaneous molecular improvement with different treatments in atopic dermatitis patients - 06/04/20
Doi : 10.1016/j.jaci.2020.01.005
Jacob W. Glickman, MA a, Celina Dubin, BA a, Joseph Han, BS a, Dante Dahabreh, BA a, Sandra Garcet, PhD b, James G. Krueger, MD, PhD b, Ana B. Pavel, PhD a, ∗ 
, Emma Guttman-Yassky, MD, PhD a, ∗
, Emma Guttman-Yassky, MD, PhD a, ∗ a Department of Dermatology and Laboratory of Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, NY
b Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY
| Disclosure of potential conflict of interest: E. Guttman-Yassky is an employee of Mount Sinai and has received research funds (grants paid to the institution) from AbbVie, Celgene, Eli Lilly, Janssen, Medimmune/Astra Zeneca, Novartis, Pfizer, Regeneron, Vitae, Glenmark, Galderma, Asana, Innovaderm, Dermira, and UCB; and is also a consultant for Sanofi Aventis, Regeneron, Stiefel/GlaxoSmithKline, MedImmune, Celgene, Anacor, AnaptysBio, Dermira, Galderma, Glenmark, Novartis, Pfizer, Vitae, Leo Pharma, AbbVie, Eli Lilly, Kyowa, Mitsubishi Tanabe, Asana Biosciences, and Promius. J. G. Krueger has received research support (grants paid to his institution) and/or personal fees from Pfizer, Amgen, Janssen, Lilly, Merck, Novartis, Kadmon, Dermira, Boehringer, Innovaderm, Kyowa, BMS, Serono, BiogenIdec, Delenex, AbbVie, Sanofi, Baxter, Paraxel, Xenoport, and Kineta. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2020
American Academy of Allergy, Asthma & Immunology. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Vol 145 - N° 4
P. 1285-1288 - avril 2020 Regresar al número
Artículo precedente
- Exposure to diesel exhaust particles increases susceptibility to invasive pneumococcal disease
- Rebecca K. Shears, Laura C. Jacques, Georgia Naylor, Lisa Miyashita, Shadia Khandaker, Filipa Lebre, Ed C. Lavelle, Jonathan Grigg, Neil French, Daniel R. Neill, Aras Kadioglu
- Identification of the first cases of complete CD16A deficiency: Association with persistent EBV infection
- A. Pérez-Portilla, M. Moraru, Alfonso Blázquez-Moreno, Philipp Kolb, María Bravo García-Morato, Thanmayi Ranganath, Gloria Esteso, Carla Gianelli, Rebeca Rodríguez-Pena, Roberto Lozano-Rodríguez, Juan Manuel Torres-Canizales, Catherine A. Blish, Mar Vales-Gomez, Hartmut Hengel, Carlos Vilches, Eduardo López-Granados, Hugh T. Reyburn
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?